PT  - JOURNAL ARTICLE
AU  - Debashree Ray
AU  - Maxwell Salvatore
AU  - Rupam Bhattacharyya
AU  - Lili Wang
AU  - Shariq Mohammed
AU  - Soumik Purkayastha
AU  - Aritra Halder
AU  - Alexander Rix
AU  - Daniel Barker
AU  - Michael Kleinsasser
AU  - Yiwang Zhou
AU  - Peter Song
AU  - Debraj Bose
AU  - Mousumi Banerjee
AU  - Veerabhadran Baladandayuthapani
AU  - Parikshit Ghosh
AU  - Bhramar Mukherjee
TI  - Predictions, role of interventions and effects of a historic national lockdown in India’s response to the COVID-19 pandemic: data science call to arms
AID  - 10.1101/2020.04.15.20067256
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.15.20067256
4099  - http://medrxiv.org/content/early/2020/04/18/2020.04.15.20067256.short
4100  - http://medrxiv.org/content/early/2020/04/18/2020.04.15.20067256.full
AB  - Importance India has taken strong and early public health measures for arresting the spread of the COVID-19 epidemic. With only 536 COVID-19 cases and 11 fatalities, India – a democracy of 1.34 billion people – took the historic decision of a 21-day national lockdown on March 25. The lockdown was further extended to May 3rd, soon after the analysis of this paper was completed.Objective To study the short- and long-term impact of an initial 21-day lockdown on the total number of COVID-19 cases in India compared to other less severe non-pharmaceutical interventions using epidemiological forecasting models and Bayesian estimation algorithms; to compare effects of hypothetical durations of lockdown from an epidemiological perspective; to study alternative explanations for slower growth rate of the virus outbreak in India, including exploring the association of the number of cases and average monthly temperature; and finally, to outline the pivotal role of reliable and transparent data, reproducible data science methods, tools and products as we reopen the country and prepare for a post lock-down phase of the pandemic.Design, Setting, and Participants We use the daily data on the number of COVID-19 cases, of recovered and of deaths from March 1 until April 7, 2020 from the 2019 Novel Coronavirus Visual Dashboard operated by the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE). Additionally, we use COVID-19 incidence counts data from Kaggle and the monthly average temperature of major cities across the world from Wikipedia.Main Outcome and Measures The current time-series data on daily proportions of cases and removed (recovered and death combined) from India are analyzed using an extended version of the standard SIR (susceptible, infected, and removed) model. The eSIR model incorporates time-varying transmission rates that help us predict the effect of lockdown compared to other hypothetical interventions on the number of cases at future time points. A Markov Chain Monte Carlo implementation of this model provided predicted proportions of the cases at future time points along with credible intervals (CI).Results Our predicted cumulative number of COVID-19 cases in India on April 30 assuming a 1-week delay in people’s adherence to a 21-day lockdown (March 25 – April 14) and a gradual, moderate resumption of daily activities after April 14 is 9,181 with upper 95% CI of 72,245. In comparison, the predicted cumulative number of cases under “no intervention” and “social distancing and travel bans without lockdown” are 358 thousand and 46 thousand (upper 95% CI of nearly 2.3 million and 0.3 million) respectively. An effective lockdown can prevent roughly 343 thousand (upper 95% CI 1.8 million) and 2.4 million (upper 95% CI 38.4 million) COVID-19 cases nationwide compared to social distancing alone by May 15 and June 15, respectively. When comparing a 21-day lockdown with a hypothetical lockdown of longer duration, we find that 28-, 42-, and 56-day lockdowns can approximately prevent 238 thousand (upper 95% CI 2.3 million), 622 thousand (upper 95% CI 4.3 million), 781 thousand (upper 95% CI 4.6 million) cases by June 15, respectively. We find some suggestive evidence that the COVID-19 incidence rates worldwide are negatively associated with temperature in a crude unadjusted analysis with Pearson correlation estimates [95% confidence interval] between average monthly temperature and total monthly incidence around the world being −0.185 [−0.548, 0.236] for January, −0.110 [−0.362, 0.157] for February, and −0.173 [−0.314, −0.026] for March.Conclusions and Relevance The lockdown, if implemented correctly in the end, has a high chance of reducing the total number of COVID-19 cases in the short term, and buy India invaluable time to prepare its healthcare and disease monitoring system. Our analysis shows we need to have some measures of suppression in place after the lockdown for the best outcome. We cannot heavily rely on the hypothetical prevention governed by meteorological factors such as temperature based on current evidence. From an epidemiological perspective, a longer lockdown between 42-56 days is preferable. However, the lockdown comes at a tremendous price to social and economic health through a contagion process not dissimilar to that of the coronavirus itself. Data can play a defining role as we design post-lockdown testing, reopening and resource allocation strategies.Software Our contribution to data science includes an interactive and dynamic app (covind19.org) with short- and long-term projections updated daily that can help inform policy and practice related to COVID-19 in India. Anyone can visualize the observed data for India and create predictions under hypothetical scenarios with quantification of uncertainties. We make our prediction codes freely available (https://github.com/umich-cphds/cov-ind-19) for reproducible science and for other COVID-19 affected countries to use them for their prediction and data visualization work.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this work. The authors will like to thank the University of Michigan Advanced Research Computing Services for enabling daily updates to our models and allocating us abundant computational resources. We will also like to thank Professor Matthew Fox from the Boston University School of Public Health for his valuable comments on our RShiny App.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and prediction codes used for analysis in this article are publicly available and are detailed in the article. http://covind19.org/